Large Cap Archives - Page 143 of 437

2 minute read

Why Is European Drugmaker Argenx Stock Sinking Today?

December 20, 10:42 AM

Argenx SE (NASDAQ: ARGX) shares plunged after the company released topline results from the ADDRESS Phase 3 study evaluating efgartigimod subcutaneous (SC) (efgartigimod alfa and hyaluronidase-qvfc) in adults with pemphigus vulgaris (PV) and

ARGX

3 minute read

‘Magnificent 7’ Widens Gap With Rest Of S&P 500, But That May Change In 2024

By Neil Dennis

December 20, 10:28 AM

The Mag7 is up 75% over the year, while the S&P 493 — the S&P 500 minus the Mag7 — is up just 12%

AAPL

1 minute read

Oil Giants Shell & Equinor Reach Sparta Investment Decision: Set To Boost Gulf Of Mexico Oil Output

By Lekha Gupta

December 20, 9:06 AM

Equinor ASA (NYSE: EQNR) and its operating co-owner, Shell Offshore Inc., a subsidiary of Shell PLC (NYSE: SHEL),

EQNR

3 minute read

Will Eye-Popping 2023 Bonuses For Wall Street Managers Alter The Santa Rally’s Course?

By Piero Cingari

December 19, 4:53 PM

Considering 2023's market performance, the bonus pool for Wall Street managers will likely surpass the record-breaking 2021 figure.

QQQ

1 minute read

Equinor Downgraded: Analyst Highlights Faster Balance Sheet Re-leveraging And Modest 2024 Distributions

By Lekha Gupta

December 19, 3:32 PM

RBC Capital Markets analyst Biraj Borkhataria downgraded Equinor ASA (NYSE: EQNR) to Sector Perform from Outperform and cut the price target

EQNR

2 minute read

Ascendis Pharma’s Growth Hormone Deficiency Candidate Outperforms in Phase 3 Trial

By Vandana Singh

December 19, 3:30 PM

Ascendis Pharma A/S (NASDAQ: ASND) released topline results from Phase 3 foresiGHt trial to compare the efficacy and safety of TransCon hGH (lonapegsomatropin) with placebo and daily hGH (human growth hormone, somatropin) in adults with growth

ASND

1 minute read

Ionis’ Strategic Shift Praised by Analysts For Donidalorsen’s Global Reach

By Vandana Singh

December 19, 3:23 PM

Monday, Ionis Pharmaceuticals Inc (NASDAQ: IONS) entered into a license agreement with Otsuka Pharmaceutical Co Ltd under which Otsuka obtains exclusive rights in Europe to commercialize donidalorsen, an investigational prophylactic treatment for

IONS

3 minute read

Tech Stocks Set New All-Time High, Small Caps On Fire As Wall Street Bulls Run Wild: What’s Driving Markets Tuesday?

By Piero Cingari

December 19, 2:55 PM

Tuesday, December 19, 2023, stands now as a remarkable day in Wall Street’s history, as the technology stocks of the Nasdaq 100 mark a significant milestone, surging to new highs after a hiatus of 758 days since their previous peak.

AAPL

1 minute read

FY24 Election Is A Major Game Changer For US Renewable Sector: Piper Analyst

By Lekha Gupta

December 19, 2:44 PM

Piper Sandler analyst Kashy Harrison revised the rating on several Renewables & Alternative Energy companies. The analyst sees benefits accruing to the installers initially (FY24) and inverters eventually (FY25), with the rest of the stock in the coverage benefiting in the long term.

ARRY

2 minute read

TotalEnergies’ Texas Solar Power: Strikes 275 MW Green Electricity Deal With LyondellBasell

By Lekha Gupta

December 19, 1:31 PM

TotalEnergies SE (NYSE: TTE)

LYB